Market revenue in 2023 | USD 23,049.5 million |
Market revenue in 2030 | USD 41,087.4 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Pre-Clinical |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Key market players worldwide | Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 75.89% in 2023. Horizon Databook has segmented the Asia Pacific healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is projected to be the fastest-growing market for clinical trials due to the changes in evaluation standards by regulatory organizations.
The growing patient pool and the outsourcing trend in the biopharmaceutical industry, particularly during the clinical stages of R&D, contribute to the growing number of clinical studies in the region. India has minimal regulations on the import & export of clinical supplies, making the process faster.
However, China has a large patient pool with a few regulatory adjustments, which is expected to contribute to its largest market share. The ease of access to a treatment-naïve patient pool in these countries drives advanced outsourcing of clinical trials and related activities.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific healthcare contract research organization market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account